FREDUN PHARMACEUTICALS
Back to Balance Sheet
|
FREDUN PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹4.48 Cr | ₹4.14 Cr | ₹3.84 Cr | ₹1.43 Cr | ₹1.38 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of FREDUN PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹4.48 Cr |
| Mar2024 | ₹4.14 Cr |
| Mar2023 | ₹3.84 Cr |
| Mar2022 | ₹1.43 Cr |
| Mar2021 | ₹1.38 Cr |
How is Deferred Tax Assets / Liabilities of FREDUN PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.48 Cr | 8.39 | |
| Mar2024 | ₹4.14 Cr | 7.65 | |
| Mar2023 | ₹3.84 Cr | 168.55 | |
| Mar2022 | ₹1.43 Cr | 3.92 | |
| Mar2021 | ₹1.38 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹812.2 Cr | 0.6% | -14.2% | 113.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹392,147.0 Cr | -2.1% | -7.7% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,208.0 Cr | -2.6% | -6.8% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,190.0 Cr | 0.1% | 5.5% | 25.3% | Stock Analytics | |
| CIPLA | ₹110,790.0 Cr | -1.9% | -9.3% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,587.0 Cr | 3.5% | -5.2% | -11.8% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | 0.6% |
-14.2% |
113.6% |
| SENSEX | -1.3% |
-3.1% |
6.8% |
You may also like the below Video Courses